Brazilian coronavirus variant likely to be more transmissible and able to evade immunity
One of those countries is Brazil. Here, they are facing a massive second wave outbreak, many daily deaths and instances of the health care systems collapsing.
Hepatitis C drugs multiply effect of COVID-19 antiviral Remdesivir
Published this week in Cell Reports, this finding - from Gaetano Montelione, a professor of chemistry and chemical biology at Rensselaer Polytechnic Institute, and his collaborators at the Icahn School of Medicine at Mount Sinai and the University of Texas at Austin - raises the potential for repurposing available drugs as COVID-19 antivirals in cases where a vaccine isn't practical or effective.
How COVID-19 impacted UK healthcare
A new study published today looks at the extent to which people managed to access NHS healthcare in April 2020, and as lockdown restrictions eased.
Artificial intelligence model predicts which key of the immune system opens the locks of coronavirus
Updated results on coronavirus vaccination effectiveness
Differing immune responses discovered in asymptomatic cases vs those with severe COVID-19
Researchers from the Wellcome Sanger Institute, Newcastle University, University College London, University of Cambridge, EMBL's European Bioinformatics Institute (EMBL-EBI) and their collaborators within the Human Cell Atlas initiative, found raised levels of specific immune cells in asymptomatic people.
More Pharma News ...
Business & Industry
- Pfizer and BioNTech to provide 500 million doses of COVID-19 vaccine to U.S. government for donation to poorest nations
- Valneva completes Phase 3 trial recruitment for its inactivated COVID-19 vaccine candidate
- Bayer to advance two first-of-its-kind cell and gene therapies for Parkinson's disease
- Pfizer and BioNTech receive first authorization in European Union for COVID-19 vaccine in adolescents
- Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the treatment of COVID-19
Research & Development
- An omega-3 that's poison for tumors
- Common diabetes drug shows promise as treatment for COVID-19 lung inflammation
- CDC COVID-19 study shows mRNA vaccines reduce risk of infection by 91 percent for fully vaccinated people
- Protein identified as new therapeutic anti-viral target for COVID-19
- Monoclonal antibody prevents HIV infection in monkeys, study finds
- NIH researchers identify potential new antiviral drug for COVID-19
- How to obtain immune bovine milk to strengthen the body against COVID-19
Conferences & Events
- Scientists urge for investment now in highly potent vaccines to prevent the next pandemic
- CPhI Worldwide to return in 2021
- Reuters Events' Cell & Gene Therapy USA
- Total health: Build a better healthcare system
- Don't fall for the 'next best action' trap
- Locking down shape-shifting spike protein aids development of COVID-19 vaccine
- COVID-19 vaccine innovation could dramatically speed up worldwide production
Regulatory Affairs
- FDA grants accelerated approval for Alzheimer's drug
- FDA approves new drug treatment for chronic weight management, first since 2014
- FDA authorizes additional monoclonal antibody for treatment of COVID-19
- FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic
- FDA and CDC lift recommended pause on Johnson & Johnson (Janssen) COVID-19 vaccine use following thorough safety review